抗苗勒管激素浓度作为女性总体健康状况指标:一项横断面研究
该单中心横断面研究纳入3163名寻求生育治疗的高加索女性,回顾性分析临床与实验室数据,以Charlson共病指数(CCI)评估共病负担。结果显示,就诊年龄<36岁(OR 1.742)和AMH≤2.3 ng/ml(OR 1.864)是CCI≥1的独立指标,提示较低AMH和较年轻就诊年龄与总体健康下降相关。
要点
- 就诊年龄<36岁(OR 1.742,95%CI 1.284-2.364)和AMH≤2.3 ng/ml(OR 1.864,95%CI 1.29-2.69)是CCI≥1的最具信息量的截断值。
- 年龄(P=0.009)、孕次(P=0.001)、AMH(P<0.001)和TSH(P=0.003)在CCI各组间差异显著。
- 就诊年龄和AMH是CCI≥1的独立指标,AMH可能作为女性总体健康状况的替代指标。
核心结论
- 就诊年龄较轻和AMH浓度较低是需要生育治疗评估的女性总体健康下降的显著独立指标。
- 如同男性精液参数一样,AMH可能作为女性总体健康状况的替代指标。
研究设计与样本
- 单中心横断面研究,纳入3163名寻求生育治疗的高加索女性。
- 所有患者接受集中实验室激素检测,整个队列的完整临床和实验室数据进行回顾性分析。
- 共病负担采用Charlson共病指数(CCI)评估,分类为0 vs 1 vs ≥2。
主要发现
- 整个队列中,CCI=0者2977名(94.1%),CCI=1者113名(3.6%),CCI≥2者73名(2.3%)。
- 年龄(P=0.009)、孕次(P=0.001)、AMH(P<0.001)和TSH(P=0.003)在CCI各组间差异显著。
- 回归模型中,就诊年龄和AMH是CCI≥1的独立指标。
- 就诊年龄<36岁(OR 1.742,95%CI 1.284-2.364)和AMH≤2.3 ng/ml(OR 1.864,95%CI 1.29-2.69)是研究人群中CCI≥1的最具信息量的截断值。
关键数值与推荐
- 就诊年龄<36岁的OR为1.742(95%CI 1.284-2.364),对应CCI≥1。
- AMH≤2.3 ng/ml的OR为1.864(95%CI 1.29-2.69),对应CCI≥1。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: To evaluate the correlation between clinical and hormonal parameters and comorbidity burden in Caucasian women presenting for fertility treatment. DESIGN: Monocentric cross-sectional study including a cohort of 3163 Caucasian women seeking medical care for fertility treatment. All patients underwent centralized laboratory testing for hormonal assessment. Complete clinical and laboratory data from the entire cohort were retrospectively analysed. Comorbidity burden score was assessed by the Charlson Comorbidity Index (CCI; categorized as 0 versus 1 versus ≥2). RESULTS: Descriptive statistics and regression models tested the associations between clinical and laboratory parameters and CCI. Among the entire cohort of patients, a CCI = 0 was found in 2977 women (94.1%), and CCI = 1 and CCI ≥2 were found in 113 (3.6%) and 73 (2.3%) patients, respectively. Age (P = 0.009), gravidity (P = 0.001), anti-Müllerian hormone (AMH, P < 0.001) and TSH (P = 0.003) values were significantly different among CCI groups. In regression models, age at presentation and AMH emerged as independent indicators of CCI ≥ 1. Age at presentation <36 years (odds ratio [OR] 1.742, 95% confidence interval [CI] 1.284-2.364) and an AMH concentration ≤2.3 ng/ml (OR 1.864, 95% CI 1.29-2.69) were the most informative cut-off values for CCI ≥ 1 in the study population. CONCLUSIONS: A younger age at presentation and lower AMH concentrations are significant independent indicators of decreased general health in women requiring clinical evaluation for fertility treatment. As observed for sperm parameters in men, AMH might serve as a proxy of women's general health status.
引用
- Vanni VS, Quartucci A, Rebecchi A, et al. Anti-Müllerian hormone concentration as an indicator of female general health status: a cross-sectional study. Reprod Biomed Online. 2021. PMID: 34815158. doi:10.1016/j.rbmo.2021.08.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。